G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?

Frontiers in Pharmacology
Sylvie Rodrigues-Ferreira, Clara Nahmias

Abstract

G-protein coupled receptors (GPCRs) constitute the largest family of membrane receptors, with high potential for drug discovery. These receptors can be activated by a panel of different ligands including ions, hormones, small molecules, and vasoactive peptides. Among those, angiotensins [angiotensin II (AngII) and angiotensin 1-7] are the major biologically active products of the classical and alternative renin-angiotensin system (RAS). These peptides bind and activate three different subtypes of GPCRs, namely AT1, AT2, and Mas receptors, to regulate cardiovascular functions. Over the past decade, the contribution of several RAS components in tumorigenesis has emerged as a novel important concept, AngII being considered as harmful and Ang1-7 as protective against cancer. Development of selective ligands targeting each RAS receptor may provide novel and efficient targeted therapeutic strategies against cancer. In this review, we focus on breast cancer to summarize current knowledge on angiotensin receptors (AT1, AT2, and Mas), and discuss the potential use of angiotensin receptor agonists and antagonists in clinics.

References

Jan 1, 1997·British Journal of Cancer·E R InwangG P Vinson
Jan 27, 1998·Genomics·N MillerP A Dervan
Mar 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·R D MachadoS P Andrade
Apr 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stefan SeiboldMartin Marx
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Jul 4, 2003·The Journal of Clinical Investigation·Kimiyasu EgamiTsutomu Imaizumi
Jul 31, 2004·Carcinogenesis·Patricia E Gallagher, E Ann Tallant
Aug 3, 2005·Trends in Endocrinology and Metabolism : TEM·Frédérique Deshayes, Clara Nahmias
Jun 7, 2006·British Journal of Cancer·M TahmasebiG P Vinson
Jun 23, 2006·Breast Cancer Research and Treatment·Jon P FryzekSøren Friis
Feb 24, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Nozomi ImaiSatoshi Umemura
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Enzo R PorrelloWalter G Thomas
Apr 3, 2009·Journal of Human Hypertension·T Rosenthal, I Gavras
Jun 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daniel R RhodesArul M Chinnaiyan
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·W Jeffrey PettyFrank M Torti
Feb 10, 2010·International Journal of Cancer. Journal International Du Cancer·Nicolas ClereDaniel Henrion
Jun 30, 2010·Cancer Cell International·Eleanor I AgerChristopher Christophi
Sep 15, 2010·Cancer Research·Katherine L CookPatricia E Gallagher
Oct 23, 2010·Nature Reviews. Cancer·Amee J GeorgeRoss D Hannan
Dec 21, 2010·Current Opinion in Pharmacology·U Muscha SteckelingsThomas Unger
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Benjamin Diop-FrimpongRakesh K Jain
Sep 23, 2011·Cancer Investigation·Young Kwang ChaeWilliam Tester
Dec 22, 2011·International Journal of Peptides·Sylvie Rodrigues-FerreiraClara Nahmias
Mar 14, 2012·Experimental Cell Research·Steven D Crowley, Thomas M Coffman
Apr 27, 2012·PloS One·Sylvie Rodrigues-FerreiraClara Nahmias

❮ Previous
Next ❯

Citations

Nov 16, 2018·ChemMedChem·Matthias HoffmannMichael Decker
Oct 6, 2017·Science Translational Medicine·Matthias Pinter, Rakesh K Jain
May 31, 2020·Cells·Filippo Acconcia
Jan 19, 2018·Oncology Letters·Min YongLina Hu
Oct 25, 2016·Physiological Research·M KvandováI Dovinová
Jun 10, 2018·Current Hypertension Reports·Alexandre ValléeJacques Blacher
Oct 2, 2020·Cancers·Fabian Bernhard Pallasch, Udo Schumacher
Jan 26, 2021·The Journal of Clinical Hypertension·Mi-Hyang JungKi-Chul Sung
Mar 24, 2021·Molecular and Cellular Endocrinology·Flávia Sardela de MirandaNaima Moustaid-Moussa
Aug 3, 2021·Frontiers in Cell and Developmental Biology·Anem IftikharIan Ellis
Jan 5, 2019·Journal of Chemical Information and Modeling·Khuraijam Dhanachandra SinghSadashiva S Karnik
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Elham AhmadianMohammad Ali Eghbal

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
xenograft
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Investigational Drugs
Robson A S SantosMaria José Campagnole-Santos
Pharmacy World & Science : PWS
J F SmitsM J Daemen
Frontiers in Endocrinology
John W WrightJoseph W Harding
Current Opinion in Nephrology and Hypertension
Johannes Stegbauer, Thomas M Coffman
© 2022 Meta ULC. All rights reserved